Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.41 -0.08 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT

Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026)

Camp4 Therapeutics (CAMP) posted Non-Current Assets of $3.3 million for Q1 2026, down 12.2% sequentially from $3.7 million in Q4 2025, and down 70.63% YoY from $11.1 million in Q1 2025.

Analysis

Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2026) Analysis & Trends

Camp4 Therapeutics has reported Non-Current Assets for 4 years, with the latest figure at $3.3 million in Q1 2026.

  • Quarterly Non-Current Assets fell 70.63% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.8 million (down 51.97% YoY) and the FY2025 annual result came in at $3.7 million, down 68.86% from the prior year.
  • Non-Current Assets fell to $3.3 million in Q1 2026 per CAMP's latest filing, from $3.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $15.9 million in Q3 2024 and troughed at $3.3 million in Q1 2026.
  • A 4-year average of $10.0 million and a median of $10.6 million in 2025 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2024 and 2026: Non-Current Assets slipped 20.15% in 2024, then plunged 70.63% in 2026.
  • Over 4 years, Non-Current Assets stood at $14.9 million in 2023, then retreated by 20.15% to $11.9 million in 2024, then sank by 68.86% to $3.7 million in 2025, then dropped by 12.2% to $3.3 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $3.3 million, $3.7 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 Camp4 Therapeutics 260.10 Mn 260.10 Mn - 3.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.40 Mn
Mar 31, 2026 3.26 Mn
Dec 31, 2025 3.71 Mn
Sep 30, 2025 8.69 Mn
Jun 30, 2025 10.19 Mn
Mar 31, 2025 11.10 Mn
Dec 31, 2024 11.92 Mn
Sep 30, 2024 15.86 Mn
Dec 31, 2023 14.93 Mn